Cargando…

117 Evaluating Predicted vs. Actual Vancomycin Pharmacokinetic Target Attainment Using AUC Dosing

INTRODUCTION: Vancomycin is a broad-spectrum antibiotic commonly used in burn patients. Traditionally, vancomycin has been managed with a trough level dosing strategy. However, recent literature and practice changes have encouraged utilizing an area under the curve (AUC) dosing strategy. The objecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyd, Allison N, Walroth, Todd A, Bollinger, Christopher, Candidate, M B A, Hartman, Brett C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correlative XV: Medical Care Non-Critical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945988/ http://dx.doi.org/10.1093/jbcr/irac012.119

Ejemplares similares

116 Clinical Impact of Transitioning from a Burn Provider-based to Hospitalist-based Sedation Service
por: Khandelwal, Anjay, et al.
Publicado: (2022)

115 Analyzing Temporal Trends and Outcomes Associated with High Prevalence Bacterial Infections in Burn Patients
por: Chokshi, Shivan N, et al.
Publicado: (2022)

120 The Association of Admission Cultures with Burn Outcomes
por: Baird, Maree, et al.
Publicado: (2022)

119 Identifying Temporal Patterns in Burn Admissions
por: Beyene, Robel, et al.
Publicado: (2022)

118 Burn Injury Vandalizes Cancer Survival with Increased Risk of Complications
por: Keys, Phillip H, et al.
Publicado: (2022)

114 Long Term Impact of Hospital Acquired Multi-drug Resistant Organisms on Health-related Quality of Life
por: Ashford, Nathaniel K, et al.
Publicado: (2022)

Educational Resource Review: The case for AUC dosing of vancomycin
Publicado: (2020)

508 A Case Report of Trichosporon asahii Burn Infection: A Not-So-Fungi
por: Boyd, Allison N, et al.
Publicado: (2022)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
por: Eum, Seenae, et al.
Publicado: (2016)

1599. AUC24 Vancomycin Bayesian-Based Dosing: Increasing Therapeutic Target Attainment with Decreased TDM Cost
por: Sabourenkov, Paul E, et al.
Publicado: (2019)

532 The Impact of a Clinical Pharmacist on Medication Management in an Adult Burn Clinic
por: Boyd, Allison, et al.
Publicado: (2023)

THE SERAPH FILTER VS THE CYTOKINE STORM
por: BARNETT, SEAN, et al.
Publicado: (2021)

1642. Vancomycin AUC(24) Estimation Using First Order Pharmacokinetic Methods in Pediatric Patients
por: Wallace, Katie L, et al.
Publicado: (2023)

CLINICAL OUTCOMES IN DIABETIC VS NON-DIABETIC PATIENTS WITH SEVERE COVID-19
por: Poon, Joseph, et al.
Publicado: (2020)

Effects of Intraosseous Tibial vs. Intravenous Vasopressin in a Hypovolemic Cardiac Arrest Model
por: Fulkerson, Justin, et al.
Publicado: (2016)

EARLY VS LATE MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19 AT A COUNTY HOSPITAL
por: ADRISH, MUHAMMAD, et al.
Publicado: (2022)

Intravenous Continuous Infusion vs. Oral Immediate-release Diltiazem for Acute Heart Rate Control
por: Means, Kimberly N., et al.
Publicado: (2018)

PRONE POSITIONING IN COVID-19 VS NON-COVID-19 ARDS IN THE EARLY COVID-19 PANDEMIC
por: LIEBERMAN, ALLYSON E, et al.
Publicado: (2022)

Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model
por: Dickneite, G., et al.
Publicado: (2009)

HIGH-DOSE VS LOW-DOSE DEXAMETHASONE IN PATIENTS WITH COVID-19 IN A TERTIARY HOSPITAL IN WESTERN HONDURAS
por: MONTALVAN, ELEAZAR, et al.
Publicado: (2021)

Open lung approach vs acute respiratory distress syndrome network ventilation in experimental acute lung injury
por: Spieth, P.M., et al.
Publicado: (2011)

Implementation of a Vancomycin AUC Monitoring Program: Peaks and Pitfalls
por: Kassamali, Zahra, et al.
Publicado: (2017)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

Direct vs Video Laryngoscopy for Difficult Airway Patients in the Emergency Department: A National Emergency Airway Registry Study
por: Ruderman, Brandon T., et al.
Publicado: (2022)

CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS MEETING VENO-VENO ECMO ELIGIBILITY CRITERIA RECEIVING ECMO VS CONVENTIONAL THERAPY ALONE
por: SIPSEY, LYNN, et al.
Publicado: (2022)

REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022)

EFFECT OF HIGH- VS LOW-DOSE OF DEXAMETHASONE ON INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS IN ACUTE HYPOXEMIC RESPIRATORY FAILURE IN SARS COV-2 PNEUMONIA
por: RAHMAN, OMAR, et al.
Publicado: (2022)

EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) VS CONVENTIONAL MECHANICAL VENTILATION FOR SEVERE ACUTE RESPIRATORY FAILURE DUE TO COVID-19: A MULTICENTER MATCHED COHORT STUDY
por: WHITMORE, SAGE, et al.
Publicado: (2022)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

775. Comparison of Initial Vancomycin Costs and Target Attainment Between Trough- and 24-Hour Area Under the Concentration–Time Curve (AUC24)-Guided Dosing
por: Laurent, David, et al.
Publicado: (2019)

Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations
por: Sujjavorakul, Kritsaporn, et al.
Publicado: (2023)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

1107. Vancomycin AUC Dosing: Is One Concentration in the Hand Worth Two in the Bush?
por: Spivey, Justin, et al.
Publicado: (2021)

599. Association between Vancomycin AUC and Clinical Failure in Patients with Streptococcal Bacteremia
por: Aycock, Anna C, et al.
Publicado: (2022)

1571. Evaluation of a Single Post First Dose Vancomycin Level to Achieve a Goal Vancomycin AUC
por: Hurley, Evan, et al.
Publicado: (2019)

Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial
por: Belperio, John, et al.
Publicado: (2023)

Population Pharmacokinetic Analysis of Pazopanib in Patients and Determination of Target AUC
por: Ozbey, Agustos Cetin, et al.
Publicado: (2021)

Stressed vs. unstressed volume and its relevance to critical care practitioners
por: Spiegel, Rory
Publicado: (2016)

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children
por: Quraishi, Ruquaya, et al.
Publicado: (2020)

220. Acute kidney injury incidence comparison of vancomycin trough-based vs AUC/MIC monitoring at a tertiary care hospital
por: Ruiz Gaviria, Rafael E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h79k6i59b8a2lbgt23ocb97pqs